Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros announces the final terms of the proposed capital increase through a discounted rights offering expected to raise up to CHF 20 million gross proceeds to advance its pipeline
Kuros announces the final terms of the proposed capital increase through a discounted rights offering expected to raise up to CHF 20 million gross proceeds to advance its pipeline
Kuros convenes Extraordinary General Meeting
Kuros convenes Extraordinary General Meeting
Kuros Biosciences obtains US patent covering a method for producing osteoinductive materials
Kuros Biosciences obtains US patent covering a method for producing osteoinductive materials